I think CTIX hands the keys to the Ferrari and lets Pfizer take complete control of K and decide how they want to commercialize/ license it. For us as investors, we will all get our big payday at that point, and Dr Menon and Leo get their ultimate goal of bringing the biggest cancer drug in history to market.

We investors always think in terms of portfolio gains and dollar signs, but these gentlemen transcend beyond simple financial concerns as they are both already well off. This is about making history, leaving a legacy, and cementing the elite status of themselves and many of their associates at the premiere cancer institutions in the world. Our scientific advisory panel is a dream team of oncology researchers because they all see the magnitude of whats about to happen here, and they want to be a part of history as well.

And of course, at the point Dr Menon will basically have unlimited funding to run KARD, and continue to follow his passion of bringing new cures to an ailing population. He and Leo will both have more than enough money to ride off into the sunset if they wish, a fitting conclusion to an epic journey that will save the lives of millions.

Truly, the nobel prize should not be out of the question here given the profound impact K will have all over the world.